Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
Schizophrenia Research|December 7, 2007
Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant miceBrian Dean, Tim Karl, Geoffrey Pavey, et al.
Schizophrenia Research|November 8, 2015
Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophreniaBrian Dean, Natalie Thomas, Chi-Yu Lai, et al.
The International Journal of Neuropsychopharmacology|July 28, 2018
Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with AspirinBrian Dean, Andrew Gibbons, Andrea Gogos, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 23, 2016
Muscarinic receptor binding changes in postmortem Parkinson's diseaseCaitlin McOmish, Geoff Pavey, Catriona McLean, et al.
Archives of Biochemistry and Biophysics|August 18, 2004
Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeysBrian Dean, Steve Chang, George A Doss, et al.
Biomedical Chromatography : BMC|June 2, 2016
A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasmaXiao Ding, Yuan Chen, Srikumar Sahasranaman, et al.
The Australian and New Zealand Journal of Psychiatry|July 25, 2009
Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosisDennis Velakoulis, Mark Walterfang, Ramon Mocellin, et al.
Psychiatry Research|December 10, 2023
Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophreniaBrian Dean, James Duce, Qiao-Xin Li, et al.
Psychoneuroendocrinology|September 9, 2016
Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactionsJeehae Sun, Adam J Walker, Brian Dean, et al.
International Journal of Endocrinology|October 23, 2015
A Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsAndrea Gogos, Alyssa M Sbisa, Jeehae Sun, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
Schizophrenia Research|December 7, 2007
Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant miceBrian Dean, Tim Karl, Geoffrey Pavey, et al.
Schizophrenia Research|November 8, 2015
Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophreniaBrian Dean, Natalie Thomas, Chi-Yu Lai, et al.
The International Journal of Neuropsychopharmacology|July 28, 2018
Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with AspirinBrian Dean, Andrew Gibbons, Andrea Gogos, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 23, 2016
Muscarinic receptor binding changes in postmortem Parkinson's diseaseCaitlin McOmish, Geoff Pavey, Catriona McLean, et al.
Archives of Biochemistry and Biophysics|August 18, 2004
Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeysBrian Dean, Steve Chang, George A Doss, et al.
Biomedical Chromatography : BMC|June 2, 2016
A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasmaXiao Ding, Yuan Chen, Srikumar Sahasranaman, et al.
The Australian and New Zealand Journal of Psychiatry|July 25, 2009
Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosisDennis Velakoulis, Mark Walterfang, Ramon Mocellin, et al.
Psychiatry Research|December 10, 2023
Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophreniaBrian Dean, James Duce, Qiao-Xin Li, et al.
Psychoneuroendocrinology|September 9, 2016
Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactionsJeehae Sun, Adam J Walker, Brian Dean, et al.
International Journal of Endocrinology|October 23, 2015
A Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsAndrea Gogos, Alyssa M Sbisa, Jeehae Sun, et al.
Pageof 25